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Gene regulationSodium is the main determinant of body ﬂuid distribution. Sodium accumulation causes water retention and,
often, high blood pressure. At the cellular level, the concentration and active transport of sodium is handled
by the enzyme Na+,K+-ATPase, whose appearance enabled evolving primitive cells to cope with osmotic
stress and contributed to the complexity of mammalian organisms. Na+,K+-ATPase is a platform at the hub
of many cellular signaling pathways related to sensing intracellular sodium and dealing with its detrimental
excess. One of these pathways relies on an intracellular sodium-sensor network with the salt-inducible
kinase 1 (SIK1) at its core. When intracellular sodium levels rise, and after the activation of calcium-related
signals, this network activates the Na+,K+-ATPase and expel the excess of sodium from the cytosol. The SIK1
network also mediates sodium-independent signals that modulate the activity of the Na+,K+-ATPase, like
dopamine and angiotensin, which are relevant per se in the development of high blood pressure. Animal
models of high blood pressure, with identiﬁed mutations in components of multiple pathways, also have
alterations in the SIK1 network. The introduction of some of these mutants into normal cells causes changes
in SIK1 activity as well. Some cellular processes related to the metabolic syndrome, such as insulin effects on
the kidney and other tissues, also appear to involve the SIK1. Therefore, it is likely that this protein, by
modulating active sodium transport and numerous hormonal responses, represents a “crossroad” in the
development and adaptation to high blood pressure and associated diseases.r Adrian I. Katz (University of
, alejandro.bertorello@ki.se
ty (Stroger) Hospital, 1901 W.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Sodium—a double-edged sword
Sodium, the most important determinant of extracellular osmo-
larity, plays a crucial role in the homeostasis and compartmental
distribution of body ﬂuids. In fact, water – the main intracorporeal
solvent – is dragged across membranes by the osmolar differences
between body compartments. No energy is spent directly to move
water; instead, pumps and transporters move sodium ions across
membranes, changing and balancing the osmolar composition of body
compartments, thus indirectly affecting the distribution of water [1].
Frequently, the sodium concentration in blood, or natremia,
reﬂects the water distribution status rather than the net sodium
content. Most patients with hypernatremia are dehydrated, and
similarly many of those with hyponatremia are over hydrated
(dilutional hyponatremia). Indeed, patients with edema can show
normal sodium concentrations in plasma but nonetheless have a totalexcess of sodium contained in the excess water in the form of edema
[2]. Alterations of sodium homeostasis can cause water to accumulate
abnormally in the intravascular compartment leading to blood
pressure elevations, as occurs in patients with sodium-sensitive
high blood pressure [3]. Most of these patients are instructed to limit
their intake of sodium, but not of water, and are frequently given
natriuretic drugs to control the blood intravascular volume and so the
blood pressure [3]. In patients with heart failure, similarly, ingestion
of free water scarcely affects their extracellular volume status, as
opposed to sodium excess, which causes volume overload and
eventually anasarca (disseminated edemas) and pulmonary edema
[4]. Sodium restriction is the paramountmeasure to prevent abnormal
accumulation of water in these patients [4]. Patients with liver
cirrhosis and portal hypertension who consume too much sodium
accumulate water in the peritoneal cavity and develop ascites; if this
happens, they are requested to limit their sodium intake and take
natriuretic drugs to correct the water excess [5]. Under ischemic
conditions such as acute stroke, the amount of energy supplied to cells
may be inadequate to maintain active sodium transport across the
plasma membrane. Sodium then accumulates in the intracellular
compartment [6]. This new status causes intracellular edema and
cellular swelling which, because of the non-compliant nature of the
skull, leads to intracranial hypertension and further exacerbates the
injury. In fact, a common strategy to prevent intracranial injury is to
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ment relatively hyperosmolar and, as a consequence, to shrink cells
back [7]. In critically ill patients, inﬂammatory injury to the lung
renders the pulmonary epithelium incapable of handling water
reabsorption, which causes accumulation of ﬂuid in interstitial and
alveolar space [8]. This situation is resolved when the alveolar
epithelial cells recover their capacity to transport sodium back from
the alveolar space to the blood [9]. Given that the resolution of
pulmonary edema is associated with decrease of mortality of critically
ill patients [10], there have been many attempts to manipulate
sodium transport in order to hasten the reversion of lung edema. The
use of diuretics [11], sodium restriction [12], delivery of sodium
transporters to the air space by using aerosolized viral vectors [13]
and other measures [14] have been proposed to hasten the resolution
of pulmonary edema.
It has also been suggested that sodium can jeopardize the
homeostasis not only through its effect on water but also on its
own. Indeed, the “normal saline” solution commonly used in clinical
settings (that contains 154 mmol of sodium per liter of water as
opposed to the ∼140 mmol/l in plasma), might be relatively harmful
compared with other formulas such as Ringer's, which has a lower
sodium content [15].
In summary, sodium is the primary determinant of water content
in the body compartments and itsmisdistribution can cause intra- and
extracellular edema, excess of intravascular water, and hypervolemia.
In addition, independently of its osmotic properties, sodium excess
can be deleterious by affecting the ionic composition of body ﬂuids,
pH, etc. Finally, as described in the next sections, intracellular sodium
per se can inﬂuence the actions of hormones and also trigger
activation of numerous signal transduction pathways, affecting
multiples cellular processes.
2. Sodium sensing—a matter of cell survival
As primitive organisms originated in the salty oceanic medium,
cells had to deal with the potential osmotic insult caused by entrance
of sodium [22]. Indeed, given that sodium is potentially toxic for many
biologically relevant components [16], cells had to develop mechan-
isms to cope with this challenge. The adaptations that have evolved
over millions of years are both complex and extremely diverse. Some
cells, such as those in plants, have a semi-rigid wall that prevents
signiﬁcant volume changes that might be detrimental to cellular
functions. The disadvantage of that “solution” is that as multicellular
organisms, plants with semi-rigid cell walls are sessile, conﬁned to
relatively ﬁxed locations, which limits their ability to escape from
adverse environmental conditions [17]. Although bacteria also have a
semi-rigid cell wall, they can migrate long distances; yet their
unicellular nature limits their complexity [17]. Mammalian cells,
despite being “extremely modern” in evolutionary terms, cannot
survive without proper control of intracellular sodium. Indeed, the
aqueous environment in which most mammalian cells are embedded
poses a threat of death by ﬂooding due to the Donnan effect. The
water-attracting power of this effect is related to the number of
intracellular molecules, which in turn is proportional to the structural
complexity of the cytosol [18]. Animal cells compensate this “sucking
force from inside” by pumping sodium towards the extracellular
milieu through the Na+,K+-ATPase located in the plasma membrane
[19]: when Na+ is actively ejected from the cell, water passively
follows. In some tissues the cost of this process corresponds to as
much as 40% of the total ATP produced. Without the Na+,K+-ATPase,
evolutionarily advanced cells are defenseless against the sodium
insult [20].
The Na+,K+-ATPase belongs to a superfamily of proteins known
as P-type ATPases, whose evolutionary links have been traced
through cloning and sequencing efforts [21]. It is accepted that the
Na+,K+-ATPase appeared only once in evolution and developed froma proton ATPase that constituted the primary cell volume regulator
at the time life evolved in the oceans [22]. Some have suggested that
plants originated in fresh water and for that reason were not
challenged with the sodium stress, an event that presumably
resulted in the development of the semi-rigid wall [17]. These
observations are signiﬁcant because they suggest that Na+,K+-
ATPase-mediated transport is not a dispensable function but an
essential requirement for evolution of animal cells. Many of the
critical properties of animal cells – not to mention the cells
themselves – might never have developed without the appearance
of the Na+,K+-ATPase. Some of these properties are indirectly yet
fundamentally affected by the Na+,K+-ATPase activity. As indicated,
the lack of the “straitjacket” represented by a semi-rigid wall allows
animal cells to integrate themselves in a complex way that makes
possible the stereotyped development pattern observed in ad-
vanced species. That complexity also demands a diverse array of
proteins to guide the construction of sophisticated cellular net-
works. Indeed, that intracellular complexity in turn contributes to
the cytosolic osmolarity that parallels the evolutionary level of
living organisms. Not surprisingly, genes related to both cell
adhesion and signaling, and genes encoding DNA-binding proteins,
which are critical for the development of multicellular eukaryotes,
are signiﬁcantly more abundant in the highly evolved organisms
such as Homo sapiens [23].
The Na+,K+-ATPase constitutes a highly versatile membrane
transport system, as the same Na+ gradient drives the transport of
H+, HCO3− and glucose. In other words, cells make use of their
strategy for coping with sodium to perform other critical functions as
well, such as nutrient uptake and pH regulation [24]. In some tissues,
epithelia for example, the localization of the Na+,K+-ATPase to the
basolateral domain of the plasma membrane is critical to vectorial
transport (i.e. from one particular place to another) of water and
solutes. In fact, loss of the pump's polarized localization is character-
istic of the renal acute tubular necrosis and causes oliguria secondary
to the inability to transport water and sodium across the tubular
epithelium [25].
Due to its exchange stoechiometry of 3 Na+ against 2 K+, the
sodium pump is, in contrast to the other P-type ATPases, electrogenic
and thereby contributes by its pumping activity directly to the
membrane potential. Many functions like ion channels' opening and
closure in excitable and nonexcitable cells would not be possible
without the activity of the Na+,K+-ATPase that establishes the Na+
gradient across plasma membranes. It has been suggested that a
single residue is responsible for the electrogenic property [26] and
that mutation in this position can abolish such property. Conversely,
the incorporation of this residue into the highly homologous, but non-
electrogenic H+,K+ gastric ATPase can render it electrogenic, which
suggests a high degree of evolutionary reﬁnement in the development
of this property [26]. Interestingly, both Na+,K+-ATPase and H+,K+-
ATPase (gastric) belong to the same branch of the P-type ATPases'
phylogenetic tree, so this subtle change seems to have occurred over a
short evolutionary time span and enabled the diversiﬁcation of tissues
[27,28]. In summary, sodium challenge appears to have caused
organisms to develop very sophisticated mechanisms that rendered
them able to perform functions of which primitive and simpler cells
were incapable.
As one delves deeper into the complexity of maintaining cell
sodium and water homeostasis, it becomes clear that the presence of
Na+,K+-ATPase in the plasma membrane provides a crucial platform
that enables various specialized mechanisms to work in a concerted
manner. Because so much depends on its function it is reasonable to
think that cells might be better “armed” if they have in place a
sodium-dependent signaling network controlling key mechanisms
(active transport via the Na+,K+-ATPase) responsible for its cellular-
andmany other secondary-derived homeostatic processes. Because of
the chaotic nature of the behavior of ions in solution, it is inferred,
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sodium ions within the intracellular milieu (largely dependent on
their effective radii) and also that this motion respect certain
hierarchy (avoid deleterious cross-talk). A required signaling system
can fulﬁll this criterion by amplifying, help to segregate in time and
space and simultaneously propagate at certain speed the signal, and
eventually efﬁciently shut down the process (Fig. 1). In the search for
potential regulators, immunochemical methods were used to isolate
proteins that were associated with the Na+,K+-ATPase subunits, and
these proteins were then identiﬁed by mass spectrometry. The
rationale for this strategy was that data obtained through the years
showed that most, if not all, regulators of Na+,K+-ATPase activity,
trafﬁcking and signaling do so by physically interacting with the Na+,
K+-ATPase subunits in what can be called a Na+,K+-ATPase-
regulatory complex [29–35]. One of such molecule is the recently
identiﬁed salt-inducible kinase 1 or SIK1 [36].
3. Sodium sensing—the SIK1 network
Salt-inducible kinase 1 (SIK1) was originally identiﬁed from
adrenal gland of rats receiving a high salt diet [37]. It is also known
as sucrose nonfermenting 1-like kinase (snf1-lk), an enzyme
originally described in yeasts [38]. A myocardial snf1-lk was
identiﬁed, but later studies indicated that it was snf1-lk, and the
myocardial form was therefore renamed [39,40]. SIK1 belongs to the
AMPK family of kinases [41] and has two related isoforms QIK (SIK2)
and QSK (SIK3). The SIK1 gene is located in chromosome 21q.22.3 and
has beenwell characterized. The QIK and QSK genes, however, are less
well deﬁned. These two genes are located close together on
chromosome 11q23.1 and 11q23.3, respectively. All three isoforms
have different molecular mass, a conserved kinase and ubiquitin
domain [42] and large variability within regulatory regions. Among
the isoforms, SIK1 has the better characterized regulatory region. A
nuclear import/export domain spans between positions 567 and 612
of the amino acid sequence [43]. Several kinase regulatory sites have
been identiﬁed, such as cAMP-dependent kinase (Ser-577) [44],
calmodulin kinase (Thr-322) [36] and LKB (Thr-182) [45] as well as an
autophosphorylation residue at Ser-186 in the A-loop, which is of
importance for its kinase activity [46].
In renal epithelial cells, SIK1 associates with the Na+,K+-ATPase
and regulates the maximal pumping capacity of the Na+,K+-ATPase
measured by an activity assay (Fig. 2). It is not known whether SIK1
interacts directly with the enzyme's α- or β-subunit (or other
subunits) or whether the interaction is structured via a linker protein.
A modest rise in intracellular sodium results in increases in Na+,K+-
ATPase activity, and this effect is blocked if SIK1 activity is suppressed
either by reducing its cellular expression (by means of siRNA), or by
transiently overexpressing a kinase-deﬁcient SIK1 [36]. The fact that
basal Na+,K+-ATPase activity (at normal intracellular sodium)
remains unaffected under conditions when SIK1 activity is sup-
pressed, indicates the possibility that only a selected pool of Na+,K+-Fig. 1. Hypothetical explanation for why animal cells need an internal sodium-sensing n
however, considering that the radius of Na+ ions in solution becomes larger due to the hyd
triggered by sodium ions mediates this effect [3]. A signaling network would provide accurATPase subunits are subject to regulation via SIK1 upon changes in
intracellular sodium. This pool is likely located at or in the vicinity of
the plasma membrane. The results also suggest that SIK1 is probably
not involved in the regulation of Na+,K+-ATPase molecules respon-
sible for constitutive transport. Increases in sodium permeability are
associated with transient increases in intracellular calcium [47], and it
is not through sodium ions directly but via a calcium–calmodulin-
dependent process that SIK1 becomes activated. CaMK1 phosphor-
ylates a Thr-322 residue within SIK1, and removal of this residue in
intact cells blocks the increases in Na+,K+-ATPase activity that
normally occur when the intracellular concentration of sodium rises
(Fig. 2). In transporting epithelia, phosphorylation of the Na+,K+-
ATPase α-subunit has been associated with clathrin-dependent
endocytosis of active α/β complex from the plasma membrane and
with the reduction in active cell sodium transport [48,49]. It has been
suggested that dephosphorylation of the Na+,K+-ATPase leads to the
elevated catalytic activity in response to physiological or pharmaco-
logical stimuli [50]. In the presence of elevated intracellular sodium,
the Na+,K+-ATPase α-subunit undergoes a calcium-dependent
dephosphorylation [36]. This effect was abolished in cells transiently
overexpressing an SIK1 mutant (lacking catalytic activity) but not in
cells expressing wild type SIK1 [36]. In renal epithelial cells, increases
in intracellular sodium activate protein phosphatase 2A (PP2A) in an
SIK1-dependent manner, and the mechanism by which SIK1 controls
PP2A activity appears to involve activation of a phosphomethylester-
ase-1 (PME-1) [36], possibly through its SIK1 consensus phosphor-
ylation site (V69YKSGSEGPV) (Fig. 2). Both PP2A (dimer PP2Ac/R65)
and PME-1 (which is known to suppress PP2A activity by demethyla-
tion of its catalytic subunit [51]) associate with the Na+,K+-ATPase
complex (Fig. 3) [36]; however, phosphorylation of PME-1 only favors
its dissociation from the Na+,K+-ATPase/PP2A complex and permits
the access of the PP2A regulatory subunit (Bs) to the PP2A catalytic
subunit, which remains bound to the Na+,K+-ATPase (Fig. 3, insert).
Thus, it is in heterotrimeric form (PP2Ac/R65/Bs) that PP2A develops
its full activity [52]. We speculate that the association of a catalytically
inactive PP2A with the Na+,K+-ATPase has a teleological justiﬁcation
because otherwise the phosphorylation state of Na+,K+-ATPase
subunits would always be tilted toward a dephosphorylated/active
state. However, experiments performed in intact cells revealed that a
proportion of Na+,K+-ATPase α-subunits are in a phosphorylated
state [48,49], suggesting the existence of various pools of Na+,K+-
ATPase that might possibly be regulated by different signaling
networks and under different conditions.
What are the structural arrangements in the cell that can hold the
components of this network together and ensure that it can be activated
in a hierarchical manner without any deleterious cross-talk? One
possibility is the scaffolding system already known to be utilized by G
protein-coupled receptors [53]. At the center of this scaffolding system
is the multiple PDZ domain protein PATJ (Pals-associated tight junction
protein). It is present in polar epithelial cells and cell lines derived from
the renal or intestinal epithelia [54] and participates in the regulation ofetwork. Increases in sodium ions could increase Na+,K+-ATPase activity directly [1],
ration cloud, and ionic movement is impeded [2], it is possible that a signaling network
ate time and space control of active sodium transport.
Fig. 2. Known partners comprising the SIK1 network that regulates active sodium
transport. CaMK: calcium–calmodulin kinase; PME-1: phosphomethylesterase 1; PP2A:
protein phosphatase 2A; NK: Na+,K+-ATPase; SIK1: salt-inducible kinase 1. Arrows
denote potential interactive/phosphorylation domains.
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of dopamine, angiotensin II and insulin signals during regulation ofNa+,
K+-ATPase activity in renal epithelial cells derived fromproximal tubule
segments. Different PDZ domains within PATJ are responsible for
mediating stimulatory (angiotensin II and insulin) versus inhibitory
(dopamine) actions on Na+,K+-ATPase activity. Whether SIK1 is
functionally linked to this scaffolding network remains to be explored.
Similarly, and also in renal epithelial cells, another PDZ domain-
containing protein (sodium hydrogen exchanger regulatory factor-1)
participates in the regulation of Na+,K+-ATPase activity in response to
parathyroid hormone [57].
Are there other sodium-regulatory processes directly involved in
cell sodium homeostasis that could be mediated by activation/
repression of SIK1 activity? Epithelial sodium channels (ENaC)
constitute the major pathway of sodium entry into cells of the
aldosterone-sensitive distal nephron. These channels are conﬁned to
the apical domain of epithelial cells and together with the Na+,K+-
ATPase (which are conﬁned to the basolateral domain), constitute the
basis of vectorial sodium transport. Similar to the Na+,K+-ATPase, the
plasma membrane ENaC activity is regulated upon changes ofFig. 3.Mechanism of PP2A activation by methylation/demethylation. An inactive PP2A
complex associates with the Na+,K+-ATPase. Inset 1: PME-1 binds to the catalytic
subunit PP2Ac (which exists as a dimer bound to the regulatory subunit, R65). SIK1-
dependent phosphorylation of PME-1 favors its dissociation from the catalytic subunit,
permitting the binding of the third PP2A regulatory (Bs) subunit, and thereby
generating the active (heterotrimer) PP2A (Inset 2).intracellular sodium [58]. This phenomenon has been attributed to
sodium ions themselves operating through a feedback mechanism
that regulate the availability of ENaC at the plasma membrane. It has
recently been demonstrated that changes in intracellular sodium
concentrations affect the proteolytic cleavage of ENaC [58]. It is not yet
resolved whether this cleavage and/or a cleavage-independent
regulation of ENaC are triggered directly by sodium ions or indirectly
through a signaling mechanism, where SIK1 could possibly be
involved. As mentioned before, the increases in intracellular sodium
elicited by monensin are paralleled by transient increases in
intracellular calcium; therefore, it is plausible that secondary
increases in intracellular calcium could play a role via CaMK-SIK1
activation.
SIK1 is not present exclusively in animal cells but is also found in
homologous form in plants [59] where a vacuolar proton pump is
activated by SOS2 (a snf-kinase) [60,61] via SOS3 (a Ca2+-dependent
kinase) [62]. This network becomes critical in the adaption (survival)
of plants to drought or to increases in the salinity of the soil. These
observations further highlight the relevance of this evolutionary
highly conserved network for the maintenance of cell sodium
homeostasis.
Teleologically, the existence of a signaling system (with CaMK-
SIK1 at its core) mediating the actions of sodium on its own transport
has several potential explanations. First, in view of the randommotion
of molecules in solution, it could facilitate the “encounter” between
sodium ions and the transporters. Because molecules and ions in
solution move randomly and the chances of them interacting with a
receptor depend on their concentration, the existence of an SIK1
network suggests that sodium actions in the cell may not only be the
consequence of behaving purely as a randomly moving molecule in
solution. In this hypothetical model, the “sodium signal” instead of
“sodium ions” could trafﬁc through the different levels of the SIK1
network using it as a molecular track that directs the signal towards
the target (Na+,K+-ATPase), without the need of a bulk increase in
intracellular sodium and in similar fashion to calcium signals through
kinases, or to phosphate transfer over the different MAP kinases'
signaling pathways in the process of phosphorelay. Second, it could
set a hierarchical organization and coordinate the work of different
mediators. Third, it could enable cells to amplify a sodium-triggered
signaling process that causes sodium to be extruded from the cell.
Without such ampliﬁcation, the signal might require a transient,
massive increase of intracellular osmolarity, which would jeopardize
the cell by the potential “intracellular ﬂooding” caused by the sodium
entrance (Fig. 4). Instead, a subtle increase in sodium permeability
would be sufﬁcient to activate intracellular mechanisms that, without
signiﬁcantly affecting the osmotic load, would exert an effect that
otherwise, with no intermediate network, could carry the risk of cell
death by ﬂooding (Fig. 4).
4. SIK networks—in addition to sodium sensing
Notwithstanding its crucial role in sodium homeostasis, the SIK
network also appears to mediate the action of hormones that react
to perturbations in that homeostasis as well as being involved in
mechanisms where ionic imbalances have no obvious inﬂuence. The
lack of ionic imbalance may be real, or it may be that the available
data – though suggestive – still does not convincingly show the
involvement of ion status. For example, SIK-dependent mechanisms
associated with insulin action and glucose metabolism have recently
been characterized. The SIK2 isoform phosphorylates (at Ser-794)
the insulin receptor substrate-1 [63], and the activity/expression of
SIK2 isoform is elevated in white adipose tissue from diabetic mice.
Moreover, SIK2 can be activated in adipocytes by nutrient
deprivation, whereas SIK2 activation suppresses the expression of
lipogenic genes [64]. It is possible that secondary changes in ion
gradients (amino acid-dependent transporters) may contribute
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dependent SIK1 pathway. Of interest, in brown adipocytes, the SIK2-
TORC2 signaling cascade mediates the effects of insulin on
peroxisome proliferator-activated receptor-coactivator-1α and
uncoupling of protein-1 gene expression [65].
The mediatory role of SIK in the actions of insulin extends beyond
the adipose tissue. In hepatocytes, SIK inﬂuences TORC activity by
direct phosphorylation [66]. SIK2-dependent phosphorylation of
TORC and its ubiquitination is utilized by insulin during inhibition
of gluconeogenesis [67]. Also in hepatocytes, SIK1 participates in the
control of lipogenesis via phosphorylation of sterol regulatory
element-binding protein 1c [68]. TORC is a key regulator of fasting
glucosemetabolism, and glucagon utilizes this mechanism to facilitate
hepatic glucose production via the stimulation of gluconeogenic genes
[69]. This effect requires the dephosphorylation of TORC by a
coactivator of cyclic AMP responsive element (CRE)-binding protein
(CREB), via calcineurin and possibly the suppression of cAMP-
dependent phosphorylation of TORC via the SIK2 isoform [70].
LKB1 is a tumor suppressor kinase involved in many pathophys-
iological processes [71]. LKB1 regulates the cellular expression and
activation of SIK1 [71], and the molecular mechanisms that mediate
this process appear to involve the phosphorylation of threonine
residues within the SIK A-loops. LKB1 and the downstream SIK
pathway also play an important role in controlling CREB activity via
the phosphorylation of TORC. Recent observations provided compel-
ling evidence indicating that SIK1 mediates the link between LKB and
p53, a critical regulator of apoptosis [72]. Loss of SIK1 function is
associated with down-regulation of p53 and increases cell invasive-
ness in certain forms of cancer.
5. Sodium sensing—hormone actions in renal epithelia
Whereas renal sodium excretion can be affected by regulating the
renal plasma ﬂow and glomerular ﬁltration rate, most hormones
under physiological variations of salt intake inﬂuence sodium
homeostasis by modulating its transport across the renal tubule
segments. By affecting the activity of speciﬁc transporters (Na+,K+-
ATPase, Na+-antiporters, Na+-channels, etc.), hormones can inﬂu-
ence the vectorial sodium transport within speciﬁc segments of the
nephron and thereby increase/decrease sodium reabsorption [73–
75]. Themultiple and concerted actions of diverse hormones along the
nephron segments all serve the ultimate goal of adjusting the sodium
excretion rate down or up depending whether the organism has
sensed a status of sodium depletion or overload. Importantly, the ﬁnal
action of certain agents (such as aldosterone, atrial and brain
natriuretic factors) will depend directly on their cellular levels and
their capacity to bind their speciﬁc receptors. In other nephron
segments, whenever natriuretic and antinatriuretic hormones operate
simultaneously, such regulation becomes more complex and not fully
understood.Fig. 4. Potential scenarios upon increase in sodium permeability in cells with/without a
cell sodium-sensing network. Lack of a sodium-sensing network may require transient
increases in intracellular sodium during vectorial transport.Most physiologic processes occur through reactions involving
molecules in water solutions.Without these reactions, life as we know
it would simply not be possible. As water distribution in the body is
driven by osmolar strengths – of which sodium is amain determinant –
the forces aimed at sodium conservation prevail in the human
organism: they serve to maintain the amount of water needed as the
“body solvent”. This means that in the absence of sodium intake, the
renal epithelia will reabsorb it from urine in order to maintain water
stores. In certain segments, such as proximal convoluted tubules
(where the bulk of sodium is reabsorbed), sodium conservation is
supported by prevailing antinatriuretic mechanisms usually under
euvolemic conditions (i.e. angiotensin, at low concentrations,
increases tubule Na+,K+-ATPase activity) [76]. Similarly, in intact
cells, the Na+,K+-ATPase operates well below its maximal capacity
[77], leaving considerable margin for increase in its activity if
physiologically needed. Contrary to the constitutive sodium-reten-
tion mechanisms, in renal proximal tubules there is a facultative
dopamine-mediated system that gets activated when there is an
excessive sodium load [78,79]. This system is initially triggered by an
increase in dopamine production within the proximal tubule [78]
and an increase in the number of dopamine receptors at the plasma
membrane of renal proximal tubules [80]. Cells in this segment do
not store dopamine: rather, they produce it directly from its
precursor, L-DOPA, the availability of which thus determines
dopamine production. The cell transport (inward/outward) of L-
DOPA is mediated in part (∼25%) via a Na+-dependent transporter
and also via a Na+-independent, pH-sensitive LAT2 transporter [an
isoform of system L (leucine preferring) that transports large
branched and aromatic neutral amino acids in a Na+-independent
manner] [81]. Both the molecular mechanisms behind the regulation
of these two L-DOPA transport systems, and whether they operate
simultaneously or independently of speciﬁc stimuli, remain to be
explored. The mechanisms that link high salt intake/increased
dopamine production and activation of L-DOPA transporters are not
known. The actions of dopamine are associated with incorporation
of dopamine receptors at the plasma membrane of tubule cells
[80,82]. Is the sole presence of higher dopamine levels within renal
proximal tubules enough to increase the availability of dopamine
receptors at the plasma membrane? Stringent analysis of the available
data indicates that this is probably not the case. Whatever the
mechanism may be, increases in dopamine content within the tubule
cell has little or no physiological relevance for dopamine action
regarding down-regulation of Na+,K+-ATPase activity, because during
inhibition of its activity, dopamine per se is ineffective. In general,
dopamine-dependent inhibition of Na+,K+-ATPase activity in renal
proximal tubules occurs when the enzyme is allowed to operate at Vmax
(highest activity). Under experimental in vitro conditions, this effect is
created artiﬁcially by raising the concentration of sodium within the
assay conditions.When cells in culture are incubatedwith dopamine, its
inhibitory action on Na+,K+-ATPase-dependent ion transport is very
poor (∼10 %) and barely signiﬁcant [83]. However, when the
intracellular concentration of sodium rises above normal levels, there
is a signiﬁcant increase inNa+,K+-ATPase activity only in cells thatwere
not exposed to dopamine. Based on this facts it is clear that sodium, is a
prerequisite and the conditioning factor inﬂuencing the cell's response
to dopamine during regulation of Na+,K+-ATPase activity and thereby
sodium transport.
Most experiments aimed at studying the role of intracellular
sodium in vitro have used permeabilized cells, a condition created by
hypotonic stress. This harsh treatment causes a number of artiﬁcial
conditions within cells that a priori prevent any meaningful
interpretation of the results, mainly because it would be impossible
to determine the magnitude and the duration of the intracellular
sodium elevation, the behavior of other ions, and more importantly
the stability of the cell architecture due to the rearrangements of the
cell cytoskeleton [84]. Because of these impediments, the role of
Fig. 5. Behavior of dopamine and angiotensin II receptor upon changes in intracellular
sodium concentrations. The transition from basal to sodium-stimulated state promotes
the redistribution of dopamine and angiotensin II receptor within the plasma
membrane and intracellular organelles (endosomes).
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of a sodium ionophore. Live cell imaging [47] provides a reliable
quantitative analysis of the intracellular concentration of sodium and
its dynamic changes over time. These studies revealed that monensin
(one of the ionophores with highest selectivity for sodium) increases
intracellular sodium over time and that, at certain concentrations, it
elicits these effects without visible changes in the cell size. Under this
optimized and controlled conditions, small elevations in intracellular
sodium resulted in increased dopamine receptor immunoreactivity at
the plasma membrane. This event coincides with the dopamine-
dependent inhibition of Na+,K+-ATPase activity [47]. Based on these
ﬁndings, it is perhaps more useful to consider the sodium factor per se
when studying dopamine receptor-related phenomena (the activa-
tion of GRK, or its ability to activate intracellular messengers) in
whole-cell systems rather than to focus independently on dopamine
actions. Because of the multiple factors affecting sodium reabsorption
in the proximal convoluted tubule, it is also relevant to ask whether it
is only the redistribution of dopamine receptors at the plasma
membrane that tilts the balance toward the dopamine-natriuretic
effect. Along with the increase in dopamine receptors at the plasma
membrane, there is a decrease in angiotensin II receptor immuno-
reactivity (Fig. 5) [80]. This strongly suggests that dopamine-
dependent decrease in Na+,K+-ATPase activity not only requires
more dopamine receptors at the plasma membrane but also a
reduction in the opposing forces (provided by angiotensin II) that
stimulate Na+,K+-ATPase and sodium reabsorption. Within renal
tubule cells, a simple increase in sodium permeability by itself cannot
generate such a complex cellular response resulting in the redistri-
bution of various hormone receptors. Whether SIK1 provides the
framework for these sodium-targeted actions remains to be explored.
Besides SIK1 being involved in the control of cell sodium
homeostasis, it is possible that the network could also be used by
hormones responsible for the increases of Na+,K+-ATPase activity in a
sodium-independent manner. For example, one such hormone could
be angiotensin II, and several experimental observations point at this
direction (Fig. 6). In cells derived from renal proximal tubules,
incubation with angiotensin II promotes an increase in SIK1 activity
(Fig. 6A). The presence of angiotensin II in picomolar (b 10 pM)
concentrations also increases Na+,K+-ATPase activity in these cells
[80]; however, if cells are transiently overexpressing SIK1 bearing a
mutation (K56M) that renders the kinase inactive, angiotensin II fails
to increase Na+,K+-ATPase activity (Fig. 6B). Angiotensin II-depen-
dent stimulation of Na+,K+-ATPase requires the incorporation of new
active subunits at the plasma membrane [35], and those units must
also be in a dephosphorylated state. Because it is known that Na+,K+-
ATPase α-subunit-dependent dephosphorylation at the plasma
membrane is mediated by SIK1→PP2A activation under sodium
stress conditions [36], it is possible that the role of SIK1 during
angiotensin II-dependent stimulation of Na+,K+-ATPase is to dephos-
phorylate the α-subunits once they have reached the plasma
membrane (Fig. 6C). Certainly, those Na+,K+-ATPase molecules
trafﬁcking to the plasma membrane in intracellular organelles do so
in an inactive state. Alternatively, SIK1 could alsomediate the trafﬁc of
Na+,K+-ATPase unit-containing vesicles to the plasma membrane
(Fig. 6C, 1 and 1′). The strength of the latter hypothesis resides on the
fact that certain cytoskeletal proteins such as kinesin heavy chain,
kinesin light chain and dynein intermediate light chain contain SIK1-
consensus phosphorylation sites, which are potential targets for
regulation.
Among multiple and interdependent factors, variations in salt
intake and the renin–angiotensin system are effective controllers of
aldosterone production during salt deprivation [85,86]. Aldosterone
synthase is at the center of the cellular mechanisms behind the
regulation of aldosterone levels; CYP11B2 gene is a known target for
angiotensin II and ACTH [87]. The potential cellular mechanism by
which angiotensin II activates CYP11B2 involves a calcium-dependentactivation of SIK1 via calmodulin kinase. It is likely that SIK1 regulates
NURR1 (Nur-related factor 1, NR4A2), which is a known mediator of
CYP11B2 activation in response to angiotensin II [88]. SIK1 can be
regulated in a cAMP-dependent manner (during ACTH-dependent
activation of CYP11b2) and in a calcium–calmodulin kinase-depen-
dent manner [89]. Both cAMP-dependent activation of SIK1 and
overexpression of SIK1 result in down-regulation of the CYP11B2
gene. During high salt intake, expression of the CYP11B2 gene in the
adrenal gland decreases, which is also associated with elevated SIK1
activity. Although the available evidence is suggestive, very little
attention has been directed to the SIK1-CYP11B2 axis, and it remains
unclear whether there is a causal relationship between these two
factors, and whether they might affect the production of aldosterone
in the adrenal glands. At the cellular level, both long-term increases in
sodium permeability and aldosterone exposure stimulate Na+,K+-
ATPase activity at distal nephron segments [90]. Depending on the
duration of the stimulus, this effect is mediated by some combination
of increased catalytic activity of available pools of Na+,K+-ATPase
units at the plasma membrane, recruitment of new molecules from
intracellular organelles or increased synthesis of new subunits [90].
Could it be that the mediatory role of SIK1 on aldosterone actions is
analogous to the effects of angiotensin II on SIK1-Na+,K+-ATPase?
Since SIK1 controls the activity of different transcription factors, it is
tempting to consider that it could also have a mediatory role in the
regulation of speciﬁc aldosterone-targeted genes within the renal
tubule segments.
6. Sodium sensing—elevations in arterial blood pressure
Despite the presence of multiple natriuretic systems (ANP,
dopamine, ouabain-like factors, marinobufagenin, etc.) that provides
a tight control of sodium homeostasis, a proportion of individuals
develop hypertension when they increase their daily salt intake.
Over the years, animal models of hypertension have provided a
useful tool for understanding the relevant mechanisms that fail at the
cellular and/or organ level and their impact on the development of high
blood pressure [91]. Moreover, the ability to manipulate speciﬁc genes
(knock-out/knock-in) has provided a signiﬁcant tool for studying
diverse cellular factors and processes and their contribution to blood
pressure regulation [91–95]. Inparticular, deﬁning the role ofNa+/Ca2+
exchanger and Na+,K+-ATPase α-subunits and their sensitivity to
ouabain provided important insights into the pathophysiology of
hypertension [96]. Each one of these hypertensive models has its
particular features, and faulty regulatory systems cannot be generalized.
Also, in some models the different cell abnormalities do not coexist.
However, despite this variability, the models have a common
denominator in the response to the salt content of the diet.
Variations in salt intake determine blood pressure [97–99].
However, in some forms of hypertension such as α-adducin-
dependent [95], elevation of arterial blood pressure may not only be
associated with the elevated salt content of the diet but also caused by
Fig. 6. Angiotensin II effects on sodium transport are mediated in part by the SIK1 network. (A) Transformed (GST-SIK1) OK cells were incubated with angiotensin II (1 pM at 23 °C)
for 5 and 10 min. SIK1 activity was determined by Western blot as the degree of phosphorylation of its T182 residue (p182) using a speciﬁc phospho-antibody. (B) Na+,K+-ATPase
activity was determined in OK cells transiently transfected with SIK1 wild type (WT), K56M mutant (which renders the kinase inactive) or nontransfected (NT) in the presence or
absence of angiotensin II. Enzyme activity was examined as ouabain-dependent rubidium transport. Each bar represents themean±SEM of 5 experiments performed independently
and in triplicate. (C) Cartoon depicting mechanistically the possible cellular mechanisms by which SIK1 may link the action of angiotensin II on Na+,K+-ATPase activity in renal
epithelial cells (for detailed explanation see text).
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tubule cells that gets exacerbated by increased salt intake [100]. For
example, basal SIK1 activity is elevated in renal proximal tubules
isolated from Milan hypertensive rats when compared to their
normotensive counterparts [101]. Similarly, when a cell line derived
from proximal tubules of the opossum kidney transiently express the
hypertensive variant of human adducin, SIK activity increases in
comparison to wild type cells. The molecular mechanisms by which a
mutant variant ofα-adducin associates with elevated SIK1 activity are
yet to be fully explored. Hypothetically, it can be attributed either to a
direct control of SIK by α-adducin, or to an indirect SIK1 activation by
increased steady-state concentrations of intracellular sodium created
by the presence of the hypertensive mutant variant of α-adducin.
In renal epithelial cells expressing the α-adducin variant carrying
the hypertensive mutation, dopamine fails to promote the endocy-
tosis of Na+,K+-ATPase subunits, and thereby the decrease in cell Na+,
K+-ATPase activity [102,103]. Themechanism that is impaired appears
to be a defective adaptor protein-2 phosphorylation/dephosphoryla-
tion process that leads to deﬁciencies in the formation of clathrin
coated pits and vesicles [102]. Additionally, in Milan rats carrying the
hypertensive variant of α-adducin it appears that ouabain has a
stimulatory effect on renal Na+,K+-ATPase activity [104] with a
consequent increase in sodium reabsorption. However, in vitro studies
in cells transiently expressing the mutant α-adducin show that
ouabain causes a decrease of Na+,K+-ATPase activity. Furthermore,
long-term exposure to ouabain is also associated with the endocytosis
of a proportion of active Na+,K+-ATPase pumps from the plasma
membrane into endosomal compartments [105]. In summary, it
appears that an array of malfunctioning systems could be responsible
for the hypertensive phenotypes associated with mutations in the
adducinmolecule. A defect in the dopamine system associatedwith an
elevated sodium transport activity could result in a net increase in
sodium reabsorption. The defect in the dopamine-natriuretic system,
although dormant, may further affect the response of these animals
when subjected to a high salt intake. In Dahl salt-sensitive rats,
dopamine also fails to down-regulateNa+,K+-ATPase activity. Another
interesting feature of the Dahl rat model is that dopamine action is
already impaired in the prehypertensive period [106], suggesting the
presence of a pre-existing factor that is not triggered by salt intake per
se. It is conceivable that there are multiple natriuretic systems that
could act simultaneously in response to a single event such as an
increase in the sodium content of the diet. This hypothesis requires
further exploration. Apart from an inherited lack of dopamine receptor
function, dopamine receptor dysfunction secondary to other factors
such as the presence of ouabain-like compounds might occur. If
elevated plasma ouabain-like factors suppressed the dopaminereceptor effects [107], it could lead to increased sodium transport
due to the lack of the inhibitory signals. This, alone or in combination
with increased salt intake, may result in increased reabsorption and
eventually lead to elevated blood pressure. Spontaneously hyperten-
sive rats (SHR) are known to have dopamine receptor abnormalities
(extensively described elsewhere in this issue); however, we still lack
information concerning whether sodium and/or other precondition-
ing factors play a role in these abnormalities or if they are purely
inherited. Could it be the case, in Milan as well as SHR rats – and in
hypertensive individuals carrying the hypertensive adducin allele –
that the actions of ATII are further potentiated by an inability of
dopamine to operate efﬁciently beyond its direct actions on its
receptors? The lack of an efﬁcient dopamine-natriuretic system may
lead to a prevailing antinatriuretic action of renal ATII on Na+,K+-
ATPase activity: if basal SIK1 activity is high, lower concentrations of
ATII might be sufﬁcient to trigger larger increases in renal tubule
reabsorption of sodium.
Hypertension is commonly observed in individuals with insulin
resistance (also known as the metabolic syndrome). The mechanisms
underlying the association of insulin resistance and diabetes with
hypertension are poorly understood. Diabetes is the leading cause of
renal dysfunction in adults. Both kidney function and insulin action
are interdependently involved in blood pressure control, electrolyte
metabolism and glucose metabolism. The renal actions of insulin
could be divided into those affecting the glomerular function and
those affecting the tubule transport. Insulin alone and elevated
plasma glucose levels reduce renal sodium excretion, most likely by
affecting proximal and/or distal tubule sodium transport and
excretion [108,109]. At the tubular level, insulin has been found to
stimulate Na+,K+-ATPase activity [110], increase sodium transport in
proximal tubules, and potentiate the antinatriuretic effects of
angiotensin II. Glucose-induced antinatriuresis is probably due to
both enhanced glucose–sodium co-transport and enhanced sodium
reabsorption in the proximal tubules during hyperglycemia. Com-
pensatory hyperinsulinemia in insulin-resistant patientsmay alter the
renal set point for sodium reabsorption by imposing a chronic
antinatriuretic driving force on the kidney (enhanced by angiotensin
II) and therefore play a critical role in the development and
maintenance of high blood pressure. In unpublished experiments,
we observed that the actions of insulin on renal proximal tubule cells
Na+,K+-ATPase activity are abrogated in cells where SIK1 has been
rendered inactive. These data provide another example of the
involvement of the renal SIK1 network in the control of key cellular
mechanisms responsible for the regulation of sodium transport and
homeostasis. Furthermore, the data highlight the possibility that
blocking SIK1 within the renal system could be of beneﬁt in
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reabsorption.
7. Sodium sensing and hypertension—outlook
As new cellular systems, membrane transporters/receptors, and
factors are discovered tobe relevant for bloodpressure control, evidence
of different dysfunctional elements emerges. Many key regulatory
proteins have been shown to have genetic variations that are associated
with high blood pressure [111–113]; however, detailed functional
studies in order to prove their causal relevancewithinmechanisms that
control arterial blood pressure, need to be further explored.
Multiple natriuretic systems are controlled by salt, probably not
directly but via numerous interdependent intermediate factors
(environment based). Furthermore, the content of salt within the
diet may not only be important for triggering a number of
maladaptative responses leading to elevated blood pressure but also
by inﬂuencing directly the action of other homeostatic systems
operating under physiological conditions.
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